An out-of-specification result was found in stability testing: at 12 months the content limits for paracetamol and ascorbic acid were exceeded; it is uncertain whether the rest of the batch meets quality requirements for active substance content. Potential effects: reduced treatment efficacy or increased adverse effects.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use product from batch 100401; check the batch number and, if you have it, return the product to a pharmacy or consult a doctor.
The medicinal product Febrisan, batch 100401, was withdrawn from the market throughout the country and the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related